Griffith on the cusp of a new vaccine modality breakthrough 3 Good Health and Well Being PublishedAugust 24, 2023October 3, 2023 AuthorEmma O'Connor Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Rainforest plant could hold key to lung fibrosis treatment Griffith Institute for Drug Discovery (GRIDD) PublishedJuly 5, 2023 AuthorCarley Rosengreen Initial results show promise for rainforest compound to treat lung fibrosis patients.
Griffith researchers reveal big Ideas in latest funding win Griffith Health PublishedDecember 19, 2022December 21, 2022 AuthorCarley Rosengreen Researchers awarded four NHMRC Ideas Grants worth more than $3.6 million.
Griffith awarded more than $4 million in NHMRC Investigator Fellowships Griffith Health PublishedOctober 14, 2022October 17, 2022 AuthorCarley Rosengreen We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).
Intranasal vaccine may deter antibiotic-resistant bacterium Centre for Cell Factories and Biopolymers PublishedApril 13, 2022March 9, 2023 AuthorContributed Griffith University researchers have developed a potential vaccine for a pathogen causing severe infection in immunocompromised people.
Put that on the CV: the impact of research Griffith Institute for Drug Discovery (GRIDD) PublishedFebruary 2, 2022March 9, 2023 AuthorCarley Rosengreen Documenting research impact made easier with Impact CV.
Ideas grants contribute to long-term health and wellbeing Griffith Health PublishedNovember 8, 2021August 17, 2022 AuthorContributed Griffith University researchers have secured more than $2.6M in NHMRC Ideas Grants.